WS #232

The dominant signal in this data dump is the escalating Iran conflict and its direct impact on global energy markets, corroborated across multiple high-signal sources. The new Iranian Supreme Leader Mojtaba Khamenei has explicitly stated the Strait of Hormuz should remain closed as a 'pressure tool against the enemy,' with reports of three more foreign vessels attacked overnight. This has driven Brent crude oil prices to surge past $100 per barrel again, with warnings of potential spikes to $200. The International Energy Agency (IEA) has responded by approving the largest-ever strategic oil reserve release of 400 million barrels, while the U.S. Department of Energy warns gas prices may not normalize until mid-2027. This geopolitical shock is already pressuring equity markets, with European indices declining and Wall Street expected to open lower, directly affecting energy stocks and broad indices like SPY and QQQ. Secondary signals include significant analyst actions with near-term price targets. DA Davidson raised its price target on Natures Sunshine Products (NATR) from $23 to $33, Wedbush raised AnaptysBio (ANAB) from $60 to $75, and B of A Securities lowered UiPath (PATH) from $14 to $12. These updates could drive volatility in these specific healthcare and technology tickers. Additionally, Nvidia's reported $36B commitment to AI partners over 30 days underscores the massive capital flows into AI infrastructure, potentially supporting NVDA and related semiconductor stocks. The broader market sentiment is being weighed down by the oil price surge, with the Ifo Institute warning the Iran war will dampen Germany's economic recovery and temporarily increase inflation, adding to global growth concerns.